118 related articles for article (PubMed ID: 17233104)
1. ABC in the news.
Carter M
IAPAC Mon; 2006 Jun; 12(6):178-9. PubMed ID: 17233104
[No Abstract] [Full Text] [Related]
2. Protease inhibitors in children: combination therapy reduced death by two thirds.
James JS
AIDS Treat News; 2001 Nov; (374):4-5. PubMed ID: 11775935
[No Abstract] [Full Text] [Related]
3. How HIV drugs work 101.
Pietrandoni G
Posit Aware; 2001; 12(5):26-7. PubMed ID: 11688481
[No Abstract] [Full Text] [Related]
4. Consider these initial combination regimens.
AIDS Alert; 2010 Apr; 25(4):40. PubMed ID: 20556895
[No Abstract] [Full Text] [Related]
5. Rescue regimens: the value of protease-inhibitor boosting.
Segal-Maurer S; Schütz M
Body Posit; 2001 Sep; 14(9):11-3. PubMed ID: 11693112
[No Abstract] [Full Text] [Related]
6. The ever-changing HIV treatment landscape.
Berger DS
Posit Aware; 2003; 14(1):69-70, 76. PubMed ID: 12630378
[No Abstract] [Full Text] [Related]
7. Anti-HIV agents. Atazanavir as a booster for protease inhibitors.
TreatmentUpdate; 2003; 15(4):1-2. PubMed ID: 17216850
[No Abstract] [Full Text] [Related]
8. Teaching adherence to substance users.
TreatmentUpdate; 2002; 14(4):4-5. PubMed ID: 12064315
[No Abstract] [Full Text] [Related]
9. HIV's potent cocktail.
Lusky K
Contemp Longterm Care; 1999 Dec; 22(12):59. PubMed ID: 10977335
[No Abstract] [Full Text] [Related]
10. Anti-HIV agents. Atazanavir and saquinavir.
TreatmentUpdate; 2004; 16(3):9-10. PubMed ID: 17219610
[No Abstract] [Full Text] [Related]
11. Improved AIDS treatments bring life and hope--at a cost.
Brink S
US News World Rep; 2001 Jan; 130(4):44-6. PubMed ID: 11211336
[No Abstract] [Full Text] [Related]
12. New versions of antiretroviral guidelines contain some important changes.
Murphy MJ
Fac Notes (New Orleans La); 1999; 11(4):1-3. PubMed ID: 11810843
[No Abstract] [Full Text] [Related]
13. Anti-HIV agents. Saquinavir--switching from Fortovase to Invirase.
TreatmentUpdate; 2004; 16(3):8-9. PubMed ID: 17219608
[No Abstract] [Full Text] [Related]
14. HIV integrase inhibitors show potent activity in clinical trials.
Winslow DL
AIDS Alert; 2007 Jan; 22(1):10-1. PubMed ID: 17722343
[No Abstract] [Full Text] [Related]
15. Antiretroviral rounds. Putting resistance to work.
Daar ES; Elion R
AIDS Clin Care; 2004 Jul; 16(7):56, 60. PubMed ID: 15300926
[No Abstract] [Full Text] [Related]
16. Buffalo hump: what the experts suggest.
Piliero PJ; McComsey GA
AIDS Clin Care; 2004 Mar; 16(3):22-3. PubMed ID: 15119294
[No Abstract] [Full Text] [Related]
17. Anti-HIV drug update.
Proj Inf Perspect; 2000 Mar; (29):6-7. PubMed ID: 12769050
[TBL] [Abstract][Full Text] [Related]
18. The current role of ritonavir-boosted protease inhibitors in the management of HIV infection.
Wilkins E
J HIV Ther; 2008 Mar; 13(1):9-18. PubMed ID: 18953268
[No Abstract] [Full Text] [Related]
19. Fosamprenavir: a new PI option. Interview by Craig Sterritt.
Nadler J
IAPAC Mon; 2004 Feb; 10(2):50-2. PubMed ID: 15106520
[No Abstract] [Full Text] [Related]
20. Controversies in current treatment guidelines.
Gazzard BG
J HIV Ther; 2008 Mar; 13(1):1-3. PubMed ID: 18953266
[No Abstract] [Full Text] [Related]
[Next] [New Search]